I did my PhD at the University of Lisbon, Portugal in host-pathogen interactions. I worked on pro- and anti-inflammatory mechanisms of dietary lipids in tuberculosis. In this context, I studied microRNA expression and function (Tuberculosis, 2016: PMID: 26980489), where I have identified miR-142-3p that is upregulated in macrophages infected with Mycobacterium tuberculosis, and I proposed the modulation of miRNAs as a novel strategy in early stage mycobacterial infections (Front Cell Infect Microbiol., 2013: PMID: 23760605). Additionally, I have identified other microRNAs involved in phagolysosome biogenesis and antigen presentation and characterized the role of cathepsins in antigen presentation (Scientific Reports, 2016: PMID: 27572605). Currently, I am a post-doctoral scientist at the University of Oxford, UK, and the main focus of my research is in vitro/in vivo infections to identify new antigens presented by HLA molecules using mass spectrometry, in malaria and tuberculosis. Also, to perform sub-clinical evaluation of new vaccines containing these antigens, through immunogenicity and efficacy studies.